✦ LIBER ✦

Focal therapy in prostate cancer: future trends

✍ Scribed by Al Barqawi; E. David Crawford

Book ID: 109051600
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 155 KB
Volume: 95
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2005.05278.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Image guidance for focal therapy of pros

Image guidance for focal therapy of prostate cancer

✍ U. Lindner; N. Lawrentschuk; J. Trachtenberg 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 312 KB

Focal or Subtotal Therapy for Early Stag

Focal or Subtotal Therapy for Early Stage Prostate Cancer

✍ J. Stephen Jones 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 164 KB

International trends in prostatic cancer

✍ David G. Zaridze; Peter Boyle; Michel Smans 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 681 KB

The most m e n t data available demonstrate a 120-fold difference between the lowest and highest incidence rates of prostatic cancer, the disease being very common in North America, particularly among Blacks, and in Scandinavia, while it is rare in Japan and other oriental countries. The highest mor

Future prospects in prostate cancer

✍ Hegarty, Nicholas J.; Fitzpatrick, John M.; Richie, Jerome P.; Scardino, Peter T 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

## BACKGROUND. Prostate cancer has displayed an increase in incidence unparalleled by any other tumor in the last two decades, with a steady, more gradual increase in mortality rate. Current curative strategies are focused on the detection and treatment of early-stage (T1-2 N0 M0), clinically signi

Benchmarks for success in focal therapy

Benchmarks for success in focal therapy of prostate cancer: cure or control?

✍ Hashim U. Ahmed; Mark Emberton 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 159 KB

Promising tumor-associated antigens for

Promising tumor-associated antigens for future prostate cancer therapy

✍ Yong Li; Paul J. Cozzi; Pamela J. Russell 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

## Abstract Prostate cancer (CaP) is one of the most prevalent malignant diseases among men in Western countries. There is currently no cure for metastatic castrate‐resistant CaP, and median survival for these patients is about 18 months; the high mortality rate seen is associated with widespread m